KELLY VISHAK: Open Payments
NPI 1124706528 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $57 · 2025 $478
Food & beverage: $403Education: $75
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $123 |
| Genentech USA, Inc. | 3 | $82 |
| ABBVIE INC. | 3 | $79 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Gilead Sciences, Inc. | 1 | $33 |
| Celgene Corporation | 1 | $27 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Genmab U.S., Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Epkinly, SCEMBLIX, Columvi, MONJUVI, Polivy, BREYANZI, IMBRUVICA, TECVAYLI.
Industry payments across OH — which companies pay providers there.
